antibody

13.08.2024 • News

MSD to Buy B-Cell Depletion Therapy from Curon

Major US drugmaker MSD is to pay up to $1.3 billion to acquire CN201, a novel investigational clinical-stage bispecific antibody for the treatment of B-cell associated diseases, from biotechnology company Curon Biopharmaceutical.

29.09.2017 • News

CMC Biologics Hikes Capacity in Denmark

26.07.2017 • News

Shire Takes Novimmune’s Blood Therapy Rights

31.05.2017 • News

Merck Takes Antibody License from Teijin

21.03.2017 • News

MRC Licenses Hepatitis C Antibody to China

28.02.2017 • News

Mundipharma to Launch Biosimilar Truxima in Europe

24.01.2017 • News

Merck Settles Keytruda Patent Disputes

02.12.2016 • News

MedImmune and Abpro Spin Out Antibody Firm

07.10.2015 • Topics • Strategy

Leaving the Patent Cliff Behind

Top-Feature

IMCD Deutschland GmbH

Fostering Innovation and Collaboration

CHEManager International c/o Wiley-VCH GmbH

Digitalization in the Chemical Industry

Ecocool GmbH

Transport Logistic: Ecocool Presents Packaging Solutions for Pharmaceutical Transports

Evonik Industries AG

Maximize the Potential of Spent Hydroprocessing Catalysts

Free Virtual Event

Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Merck & Co

EvaluatePharma